Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

Ontology Browser
Term:
Parent Terms Term With Siblings Child Terms
antagonist +     
protein kinase inhibitor +     
(+)-makassaric acid 
(+)-subersic acid 
1,4-diamino-2,3-dicyano-1,4-bis(phenylthio)butadiene 
1,8-dihydroxy-4-nitroxanthen-9-one 
2-(\{2-[(3-hydroxyphenyl)amino]pyrimidin-4-yl\}amino)benzamide 
adenosine receptor antagonist +   
alpha1B-adrenoceptor antagonist +  
aminopurvalanol 
AMPA receptor antagonist +   
AP-1 antagonist +   
aryl hydrocarbon receptor antagonist +   
Aurora kinase inhibitor +   
bone morphogenetic protein receptor antagonist +   
bradykinin receptor antagonist +   
C-X-C chemokine receptor type 4 antagonist +   
calcium channel blocker +   
calmodulin antagonist +   
cannabinoid receptor antagonist +   
capsaicin receptor antagonist +   
carbon dioxide  
chemokine receptor 2 antagonist +  
chemokine receptor 5 antagonist +   
CMB4563 
CZC8004 
DMH1 
dopamine receptor D2 antagonist +   
dopaminergic antagonist +   
EC 2.7.10.* (protein-tyrosine kinase) inhibitor +   
EC 2.7.11.* (protein-serine/threonine kinase) inhibitor +   
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor +   
epidermal growth factor receptor antagonist +   
An antagonist at the epidermal growth factor receptor.
erlotinib +   
erlotinib hydrochloride  
estrogen receptor antagonist +   
excitatory amino acid antagonist +   
fibroblast growth factor receptor antagonist +   
G-15 
G-protein-coupled receptor antagonist +   
GABA antagonist +   
GABA-gated chloride channel antagonist +   
gamma-mangostin 
glucocorticoid receptor antagonist +   
glutamine antagonist +   
glycine receptor antagonist +   
histamine antagonist +   
hormone antagonist +   
IAP antagonist +   
insulin-like growth factor receptor 1 antagonist +   
IP3 receptor antagonist +   
LRH-1 antagonist +  
lymphocyte function-associated antigen-1 antagonist +  
lysophosphatidic acid receptor antagonist +  
melanin-concentrating hormone receptor antagonist +  
melatonin receptor antagonist +   
metabotropic glutamate receptor antagonist +   
miltefosine  
mTOR inhibitor +   
neurokinin-1 receptor antagonist +   
neurokinin-3 receptor antagonist +  
neuropeptide FF receptor antagonist +  
neuropeptide Y receptor antagonist +  
neuropilin receptor antagonist +  
nicotinic acid adenine dinucleotide phosphate receptor antagonist +  
odorant receptor antagonist +   
opioid receptor antagonist +   
orexin receptor antagonist +   
pelitinib +  
piceatannol +  
platelet glycoprotein-IIb/IIIa receptor antagonist +   
platelet-activating factor receptor antagonist +   
PMX-205 
prostaglandin receptor antagonist +  
purinergic receptor P2 antagonist +   
purvalanol B 
quercetin +   
retinoic acid receptor antagonist +   
Ro 320-1195 +  
salt-inducible kinase 2 inhibitor +  
sangivamycin 
SMO receptor antagonist +   
sphingosine-1-phosphate receptor antagonist +   
substance P receptor antagonist +   
TGFbeta receptor antagonist +   
thromboxane A2 antagonist +   
TNP-ATP  
tropomyosin-related kinase B receptor antagonist +   
tyrosine kinase inhibitor +   
vascular endothelial growth factor receptor antagonist +   
vitamin B1 antagonist +  
vitamin K antagonist +   
XMD8-92 

Synonyms
Related Synonyms: EGFR antagonoist ;   EGFR antagonoists ;   EGFR inhibitor ;   EGFR inhibitors ;   epidermal growth factor receptor antagonists ;   epidermal growth factor receptor inhibitor ;   epidermal growth factor receptor inhibitors
Xrefs: Wikipedia:Epidermal_growth_factor_receptor

paths to the root